Control of telomere length by the human telomeric protein TRF1
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Human telomeres, the nucleoprotein complexes at chromosome ends, consist of tandem arrays of TTAGGG repeats bound to specific proteins. In normal human cells, telomeres shorten with successive cell divisions, probably due to the terminal sequence loss that accompanies DNA replication. In tumours and immortalized cells, this decline is halted through the activation of telomerase, a reverse transcriptase that extends the telomeric TTAGGG-repeat arrays. Telomere length is stable in several immortal human-cell lines, suggesting that a regulatory mechanism exists for limiting telomere elongation by telomerase. Here we show that the human telomeric-repeat binding factor TRF1 (ref. 8) is involved in this regulation. Long-term overexpression of TRF1 in the telomerase-positive tumour-cell line HT1080 resulted in a gradual and progressive telomere shortening. Conversely, telomere elongation was induced by expression of a dominant-negative TRF1 mutant that inhibited binding of endogenous TRF1 to telomeres. Our results identify TRF1 as a suppressor of telomere elongation and indicate that TRF1 is involved in the negative feedback mechanism that stabilizes telomere length. As TRF1 does not detectably affect the expression of telomerase, we propose that the binding of TRF1 controls telomere length in cis by inhibiting the action of telomerase at the ends of individual telomeres.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TRF1 can serve to modulate telomere length, but it also serves to facilitate DNA replication through the telomere repeats, which acts as fragile DNA sites (5)(6)(7).”
From Telomeres and telomerase in cancer (2010) · cites this paper as [5]
In the citing paper
“TRF1 and TRF2 bind the double-stranded telomere.”
From Telomeres and telomerase in cancer (2010) · cites this paper as van Steensel,B. et al. (1997)
In the citing paper
“Telomere length in human cells is controlled by a homeostasis mechanism that involves telomerase and the negative regulator of telomere length, TRF1 (TTAGGG repeat binding factor 1).”
From Control of Human Telomere Length by TRF1 and TRF2 (2000) · cites this paper as [44]
In the citing paper
“In this system, TRF1 did not affect the activity of telomerase detectable in cell extracts, suggesting that TRF1 does not affect telomerase activity globally in the cell.”
From Control of Human Telomere Length by TRF1 and TRF2 (2000) · cites this paper as [44]
In the citing paper
“Conversely, the expression of a dominant negative allele of TRF1, which removes endogenous TRF1 from telomeres, leads to telomere elongation.”
From Control of Human Telomere Length by TRF1 and TRF2 (2000) · cites this paper as [44]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
Morin, G. B. (1989) · Cell · doi:10.1016/0092-8674(89)90035-4 · Cited by 1,495
Structure and variability of human chromosome ends.
de Lange, T., Shiue, L., Myers, R. M., Cox, D. R., Naylor, S. L., Killery, A. M., & Varmus, H. E. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.518 · Cited by 848
Progress towards a quantitative understanding of Antarctic ozone depletion
Solomon, S. (1990) · Nature · doi:10.1038/347347a0 · Cited by 734
Chong, L., van Steensel, B., Broccoli, D., Erdjument-Bromage, H., Hanish, J., Tempst, P., & de Lange, T. (1995) · Science · doi:10.1126/science.270.5242.1663 · Cited by 694
Cited by
Items 401–500 of 1,000
Zhou, X. Z., Huang, P., Shi, R., Lee, T. H., Lu, G. H., Zhang, Z., Bronson, R. T., & Lu, K. P. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43452 · Cited by 65
“Moreover, PinX1 is recruited to telomeres by TRF1 and provides a critical link between TRF1 and telomerase inhibition to help maintain telomeres at the optimal length (46).”
BackgroundInfluentialZhou, W.-J., Deng, R., Zhang, X.-Y., Feng, G.-K., Gu, L.-Q., & Zhu, X.-F. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0244 · Cited by 61
Vaziri, H., Chapman, K., Guigova, A., Teichroeb, J., Lacher, M., Sternberg, H., Singec, I., Briggs, L., Wheeler, J., Sampathkumar, J., et al. (2010) · Regenerative Medicine · doi:10.2217/rme.10.21 · Cited by 61
Telomere dysfunction and cell survival: roles for distinct TIN2-containing complexes
Kim, S.-H., Davalos, A. R., Heo, S.-J., Rodier, F., Zou, Y., Beausejour, C., Kaminker, P., Yannone, S. M., & Campisi, J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200710028 · Cited by 61
“Perturbations to either TRF1 or TRF2, or their associated proteins POT1, hRap1 or TIN2, influence both telomere length and capping (Iwano et al., 2004; Kim et al., 2004; Kim et al., 1999; Loayza and De Lange, 2003; van Steensel and de Lange, 1997; Yang et al., 2005).”
BackgroundTelomeres in the chicken: genome stability and chromosome ends
Delany, M. E., Daniels, L. M., Swanberg, S. E., & Taylor, H. (2003) · Poultry Science · doi:10.1093/ps/82.6.917 · Cited by 73
Mattson, M. P., Fu, W., & Zhang, P. (2001) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00221-4 · Cited by 69
Solution structure of the DNA-binding domain of human telomeric protein, hTRF1
Nishikawa, T., Nagadoi, A., Yoshimura, S., Aimoto, S., & Nishimura, Y. (1998) · Structure · doi:10.1016/s0969-2126(98)00106-3 · Cited by 65
Telomerase and telomere-binding proteins: Controlling the endgame
Shore, D. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01082-7 · Cited by 70
Telomeric armor: the layers of end protection
Oganesian, L., & Karlseder, J. (2009) · Journal of Cell Science · doi:10.1242/jcs.050567 · Cited by 66
Kamranvar, S. A., Chen, X., & Masucci, M. G. (2013) · Oncogene · doi:10.1038/onc.2013.189 · Cited by 63
Nek4 Regulates Entry into Replicative Senescence and the Response to DNA Damage in Human Fibroblasts
Nguyen, C. L., Possemato, R., Bauerlein, E. L., Xie, A., Scully, R., & Hahn, W. C. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00436-12 · Cited by 68
“To determine if alterations in NEK4 expression affected telomere length or telomerase activity, we manipulated NEK4 expression in BJ and HT-1080 cells, which show intermediate telomere length and telomerase activity and therefore can be monitored for alterations in telomere length in the setting of constitutive expres…”
BackgroundTelomeres in Plants and Humans: Not So Different, Not So Similar
Schrumpfová, P. P., Fojtová, M., & Fajkus, J. (2019) · Cells · doi:10.3390/cells8010058 · Cited by 62
Therapeutic strategies for targeting telomerase in cancer
Chen, X., Tang, W., Shi, J., Liu, M. M., & Liu, X. (2019) · Medicinal Research Reviews · doi:10.1002/med.21626 · Cited by 65
Crisis intervention: The role of telomerase
Lustig, A. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3339 · Cited by 69
A Plant Gene Encoding a Myb-like Protein That Binds Telomeric GGTTTAG Repeats in Vitro
Chen, C. M., Wang, C. T., & Ho, C. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009659200 · Cited by 61
Role of Human Ku86 in Telomere Length Maintenance and Telomere Capping
Jaco, I., Muñoz, P., & Blasco, M. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1381 · Cited by 70
Association of Nucleoside Diphosphate Kinase nm23-H2 with Human Telomeres
Nosaka, K., Kawahara, M., Masuda, M., Satomi, Y., & Nishino, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.8097 · Cited by 60
Chromosome 18q allelic loss and prognosis in stage II and III colon cancer
Lanza, G., Matteuzzi, M., Gafá, R., Orvieto, E., Maestri, I., Santini, A., & del Senno, L. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980821)79:4<390::aid-ijc14>3.0.co;2-9 · Cited by 141
Meiotic telomeres: a matchmaker for homologous chromosomes
Hiraoka, Y. (1998) · Genes to Cells · doi:10.1046/j.1365-2443.1998.00205.x · Cited by 60
Human XPF controls TRF2 and telomere length maintenance through distinctive mechanisms
Wu, Y., Mitchell, T. R. H., & Zhu, X. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.08.004 · Cited by 67
Induction of a p95/Nbs1‐mediated S phase checkpoint by telomere 3′ overhang specific DNA
Eller, M. S., Li, G., Firoozabadi, R., Puri, N., & Gilchrest, B. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0197com · Cited by 60
“Telomere length was determined essentially as described by van Steensel and de Lange ( 44 ) using the Telo TAGGG Telomere Length Assay from Roche Molecular Biochemicals (Indianapolis, IN) and the protocol supplied by the manufacturer.”
MethodFission Yeast Taz1 and RPA Are Synergistically Required to Prevent Rapid Telomere Loss
Kibe, T., Ono, Y., Sato, K., & Ueno, M. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-12-1084 · Cited by 60
“TRF2 is linked by TIN2 to TRF1, another human telomeric DNA binding protein, which acts as a negative regulator of telomerase ( van Steensel and de Lange, 1997; de Lange, 2005).”
BackgroundEvolution of cancer suppression as revealed by mammalian comparative genomics
Tollis, M., Schiffman, J. D., & Boddy, A. M. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.12.004 · Cited by 62
RNA Binding Proteins and Genome Integrity
Nishida, K., Kuwano, Y., Nishikawa, T., Masuda, K., & Rokutan, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071341 · Cited by 54
“TRF1 is a component of the shelterin protein complex that regulates telomere length by modulating the accessibility of telomerase to telomeres [51].”
BackgroundKim, H., Li, F., He, Q., Deng, T., Xu, J., Jin, F., Coarfa, C., Putluri, N., Liu, D., & Songyang, Z. (2017) · Cell Discovery · doi:10.1038/celldisc.2017.34 · Cited by 56
Mitotic functions of poly(ADP-ribose) polymerases
Slade, D. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.028 · Cited by 59
Laprade, H., Querido, E., Smith, M. J., Guérit, D., Crimmins, H., Conomos, D., Pourret, E., Chartrand, P., & Sfeir, A. J. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.005 · Cited by 64
Telomere Rapid Deletion Regulates Telomere Length in Arabidopsis thaliana
Watson, J. M., & Shippen, D. E. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02059-06 · Cited by 58
“Telomerase is subjected to both positive and negative regulation in cis on the chromosome terminus, mitigating its ability to extend any given telomere (1, 31, 37, 42, 49, 50, 52).”
BackgroundUnderstanding spitzoid tumours: new insights from molecular pathology
Forno, P. D., Fletcher, A. A., Pringle, J. H., & Saldanha, G. S. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08207.x · Cited by 60
Mechanism-based combination telomerase inhibition therapy
Shay, J. W., & Wright, W. E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.12.012 · Cited by 61
Campbell, L. J., Fidler, C., Eagleton, H., Peniket, A., Kušec, R., Gal, S., Littlewood, T. J., Wainscoat, J. S., & Boultwood, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404141 · Cited by 61
Generation and Characterization of Telomere Length Maintenance in Tankyrase 2-Deficient Mice
Chiang, Y. J., Nguyen, M.-L., Gurunathan, S., Kaminker, P., Tessarollo, L., Campisi, J., & Hodes, R. J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2037-2043.2006 · Cited by 57
“Overexpression of TRF1 in telomerase-expressing cell lines results in telomere shortening, while expression of a dominant-negative (DN) TRF1 causes telomere elongation (3, 36).”
BackgroundKishi, S., Wulf, G. M., Nakamura, M., & Lu, K. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204229 · Cited by 64
Casagrande, V., Salvati, E., Alvino, A., Bianco, A., Ciammaichella, A., D’Angelo, C., Ginnari‐Satriani, L., Serrilli, A. M., Iachettini, S., Leonetti, C., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1013665 · Cited by 62
Hashimoto, Y., Murakami, Y., Uemura, K., Hayashidani, Y., Sudo, T., Ohge, H., Fukuda, E., Shimamoto, F., Sueda, T., & Hiyama, E. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0383-9 · Cited by 59
“Human telomeres are nucleoprotein complexes consisting of 8–15 kb of TTAGGG repeats along with specific binding proteins and are located at chromosomes ends.(18,19)”
BackgroundThe number of vertebrate repeats can be regulated at yeast telomeres by Rap1‐independent mechanisms
Brevet, V., Berthiau, A., Civitelli, L., Donini, P., Schramke, V., Géli, V., Ascenzioni, F., & Gilson, É. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg155 · Cited by 57
Telomerase Inhibition Using Azidothymidine in the HT-29 Colon Cancer Cell Line
Brown, T. A., Sigurdson, E. R., Rogatko, A., & Broccoli, D. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.03.032 · Cited by 60
GNL3L stabilizes the TRF1 complex and promotes mitotic transition
Zhu, Q., Meng, L., Hsu, J. K., Lin, T., Teishima, J., & Tsai, R. Y. L. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200812121 · Cited by 65
Cosconati, S., Rizzo, A., Trotta, R., Pagano, B., Iachettini, S., Tito, S. D., Lauri, I., Fotticchia, I., Giustiniano, M., Marinelli, L., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301019w · Cited by 57
Curvilinear telomere length dynamics in a squamate reptile
Újvári, B., Biro, P. A., Charters, J. E., Brown, G. P., Heasman, K., Beckmann, C., & Madsen, T. R. L. (2016) · Functional Ecology · doi:10.1111/1365-2435.12764 · Cited by 61
Nek7 Protects Telomeres from Oxidative DNA Damage by Phosphorylation and Stabilization of TRF1
Tan, R., Nakajima, S., Wang, Q., Sun, H., Xue, J., Wu, J., Hellwig, S., Zeng, X., Yates, N. A., Smithgall, T. E., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.01.015 · Cited by 60
TINF2 is a haploinsufficient tumor suppressor that limits telomere length
Schmutz, I., Mensenkamp, A. R., Takai, K., Haadsma, M., Spruijt, L., de Voer, R. M., Choo, S.-A. S., Lorbeer, F. K., van Grinsven, E. J., Hockemeyer, D. F., et al. (2020) · eLife · doi:10.7554/elife.61235 · Cited by 62
Telomeres in Mammalian Male Germline Cells
Zalenskaya, I. A., & Zalensky, A. O. (2002) · International review of cytology · doi:10.1016/s0074-7696(02)18011-9 · Cited by 65
Human Embryonic Stem Cells: Mechanisms to Escape Replicative Senescence?
Zeng, X. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-9005-x · Cited by 62
“Other proteins such as TRF1 and TRF2 which are involved in the maintenance of telomeres [36, 37] are also present at high levels in hESCs.”
BackgroundColeman, J., Baird, D. M., & Royle, N. J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.9.1637 · Cited by 55
DNA damage transiently increases TRF2 mRNA expression and telomerase activity
Klapper, W., Qian, W., Schulte, C., & Parwaresch, R. M. (2003) · Leukemia · doi:10.1038/sj.leu.2403086 · Cited by 60
Yin, Q., Tang, T.-T., Lu, X., Ni, W.-J., Yin, D., Zhang, Y., Wen, Y., Jiang, W., Zhang, Y., Li, Z.-L., et al. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-024-01708-5 · Cited by 58
“TRF1 has been implicated in telomere length regulation and telomere fusion [38–40].”
BackgroundSalhab, M., Jiang, W. G., Newbold, R. F., & Mokbel, K. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9622-8 · Cited by 59
“Telomere maintenance in mammalian (including human) cells is also regulated by telomere binding proteins, including telomeric repeat binding factors 1 (TRF1) and TRF2 [42, 43].”
BackgroundInfluentialAugereau, A., T'kint de Roodenbeke, C., Simonet, T., Bauwens, S., Horard, B., Callanan, M., Leroux, D., Jallades, L., Salles, G., Gilson, E., et al. (2011) · Blood · doi:10.1182/blood-2010-07-295774 · Cited by 49
The human telomere and its relationship to human disease, therapy, and tissue engineering
Moon, I. (2007) · Frontiers in Bioscience · doi:10.2741/2412 · Cited by 54
“Overexpression of TRF1 led to a telomere shortening phenotype whereas expression of a dominant negative mutant of TRF1, that lacked the Myb domain but retained the dimerization and nuclear localization domains, resulted in telomere lengthening (75, 76).”
BackgroundRap1P and Telomere Length Regulation in Yeast
Marcand, S., Wotton, D., Gilson, É., & Shore, D. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515433.ch6 · Cited by 73
Hong, J.-P., Byun, M. Y., Koo, D., An, K., Bang, J.-W., Chung, I. K., An, G., & Kim, W. T. (2007) · The Plant Cell · doi:10.1105/tpc.107.051953 · Cited by 62
“This raises the tantalizing possibility that RTBP1 inhibits the action of telomerase at the extreme ends of telomeres in vivo, as is the case for human TRF1/ PIN2 (van Steensel and de Lange, 1997; Wotton and Shore, 1997; Smogorzewska et al., 2000).”
BackgroundBisht, K. K., Dudognon, C., Chang, W. G., Sokol, E. S., Ramirez, A., & Smith, S. H. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00258-12 · Cited by 57
“Tankyrase 1 was initially identified as a binding partner of TRF1, the double-stranded DNA telomere repeat binding protein that coats human telomeres and negatively regulates telomere length (31, 33).”
BackgroundDistinct Requirements for Pot1 in Limiting Telomere Length and Maintaining Chromosome Stability
Bunch, J. T., Bae, N. S., Leonardi, J., & Baumann, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5567-5578.2005 · Cited by 62
“In cultured human cells, moderate reduction in hPot1 or Ptop/Pip1/Tint1 levels by RNA interference led to telomere lengthening, as did overexpression of a small peptide of Ptop/ Pip1/Tint1 encompassing the Pot1 interaction domain or disruption of the Trf1 complex (36, 55, 59, 63).”
BackgroundTelomere transitions in yeast: the end of the chromosome as we know it
Cooper, J. P. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00070-8 · Cited by 63
DNA excision repair at telomeres
Jia, P., Her, C., & Chai, W. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.09.017 · Cited by 63
Sharif, R., Thomas, P., Zalewski, P. D., & Fenech, M. F. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0248-4 · Cited by 54
“The role of TANK1 involves displacing TRF1 from telomeric DNA and suggests that TANK1 may be a positive regulator of telomere length in telomerase-expressing cells (Smith and de Lange 2000; van Steensel and de Lange 1997).”
Ozer, H. L. (1999) · Progress in molecular and subcellular biology · doi:10.1007/978-3-662-06227-2_6 · Cited by 57
Effects of androgens on telomerase activity in normal and malignant prostate cells in vitro
Soda, H., Raymond, É., Sharma, S., Lawrence, R. A., Davidson, K. K., Oka, M., Kohno, S., Izbicka, E., & Hoff, D. D. V. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000515)43:3<161::aid-pros1>3.0.co;2-o · Cited by 54
Controlling your losses: conditional gene silencing in mammals
Porter, A. C. G. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(97)01326-7 · Cited by 61
Nucleostemin prevents telomere damage by promoting PML-IV recruitment to SUMOylated TRF1
Hsu, J. K., Lin, T., & Tsai, R. Y. L. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201109038 · Cited by 58
“…Zhu et al., 2006, 2009; Tsai, 2009), which serves several key functions, including chromosomal end protection (Martínez et al., 2009), telomere shortening (van Steensel and de Lange, 1997), mitotic progression (Zhou et al., 2003, 2009), and APB formation (Potts and Yu, 2005; Jiang et al., 2007).”
BackgroundPoly(ADP-ribose) polymerase inhibitors as promising cancer therapeutics
He, J., Yang, C., & Miao, Z. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.103 · Cited by 56
Amir, M., Κhan, P., Queen, A., Dohare, R., Alajmi, M. F., Hussain, A., Islam, A., Ahmad, F., & Hassan, M. I. (2020) · Cells · doi:10.3390/cells9020359 · Cited by 58
Sealey, D., Zheng, L., Taboski, M. A. S., Cruickshank, J., Ikura, M., & Harrington, L. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1160 · Cited by 70
Figueroa, R. R., Lindenmaier, H., Hergenhahn, M., Nielsen, K. V., & Boukamp, P. (2000) · PubMed · Cited by 60
Sister telomeres rendered dysfunctional by persistent cohesion are fused by NHEJ
Hsiao, S. J., & Smith, S. H. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200810132 · Cited by 57
Telomerase Activity and Prognosis in Primary Breast Cancers
Carey, L., Kim, N. W., Goodman, S. N., Marks, J. R., Henderson, G. S., Umbricht, C. B., Dome, J. S., Dooley, W. C., Amshey, S. R., & Sukumar, S. V. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3075 · Cited by 53
Cyclin B-dependent kinase 1 regulates human TRF1 to modulate the resolution of sister telomeres
McKerlie, M., & Zhu, X. (2011) · Nature Communications · doi:10.1038/ncomms1372 · Cited by 60
“Removal of TRF1 from telomeres promotes telomerase-dependent telomere lengthening whereas overexpression of TRF1 leads to telomere shortening, implying that binding of TRF1 to telomeric DNA negatively regulates the access of telomerase to the ends of telomeres 15–17 .”
Cockayne Syndrome group B protein interacts with TRF2 and regulates telomere length and stability
Batenburg, N. L., Mitchell, T. R. H., Leach, D. M., Rainbow, A. J., & Zhu, X. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks745 · Cited by 58
Chronic corticosterone-induced depression mediates premature aging in rats
Xie, X., Shen, Q., Ma, L., Chen, Y., Zhao, B., & Fu, Z. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.12.073 · Cited by 55
Oroxylin A inhibits ethanol‐induced hepatocyte senescence via YAP pathway
Jin, H., Lian, N., Bian, M., Zhang, C., Chen, X., Shao, J., Wu, L., Chen, A., Guo, Q., Zhang, F., et al. (2018) · Cell Proliferation · doi:10.1111/cpr.12431 · Cited by 52
Kwon, C., & Chung, I. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312011200 · Cited by 56
Telomerase: Dr Jekyll or Mr Hyde?
Prescott, J. C., & Blackburn, E. H. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80055-0 · Cited by 59
Caspase-Dependent Apoptosis Induced by Telomere Cleavage and TRF2 Loss
Multani, A. S., Özen, M., Narayad, S., Kumar, V., Chandra, J., McConkey, D. J., Newman, R. A., & Pathak, S. (2000) · Neoplasia · doi:10.1038/sj.neo.7900105 · Cited by 52
YAP accelerates vascular senescence via blocking autophagic flux and activating mTOR
Pan, X., Wu, B., Fan, X., Xu, G., Ou, C., & Chen, M. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15902 · Cited by 52
Rb and E2F-1 regulate telomerase activity in human cancer cells
Crowe, D. L., & Nguyen, D. C. (2001) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00296-7 · Cited by 56
Telomere length maintenance in aging and carcinogenesis.
Aragona, M., Maisano, R., Panetta, S., Giudice, A., Morelli, M., Torre, I. L., & Torre, F. L. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.5.981 · Cited by 52
Putative Telomere-Recruiting Domain in the Catalytic Subunit of Human Telomerase
Armbruster, B. N., Etheridge, K. T., Broccoli, D., & Counter, C. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.9.3237-3246.2003 · Cited by 51
“Expression of the related telomere binding protein hTRF1 lacking its DNA binding domain causes telomere length to increase in telomerase-positive cells (29), possibly by destabilizing the telomere structure and allowing telomerase more access to telomeres.”
BackgroundPrescott, J. C., & Blackburn, E. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2941-2948.2000 · Cited by 49
“Mutations that disrupt the binding of TRF2 to telomeres cause telomeretelomere fusions and apoptosis, suggesting that TRF2 protects the telomeric terminus (19, 40).”
BackgroundInfluentialMadonna, R., De Caterina, R., Willerson, J. T., & Geng, Y.-J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq450 · Cited by 49
“It binds to telomeres as a homodimer with a C-terminal helix-turn-helix motif and acts as an inhibitor of telomerasedependent elongation of telomeres by limiting the access of telomerase to the telomere.(26) TRF-2 differs from TRF-1 in that its N-terminus is basic rather than acidic.”
BackgroundNonhistone targets of KAT2A and KAT2B implicated in cancer biology
Bondy‐Chorney, E., Denoncourt, A. M., Sai, Y., & Downey, M. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0297 · Cited by 51
Physical activity, a modulator of aging through effects on telomere biology
Semeraro, M. D., Smith, C., Kaiser, M., Levinger, I., Duque, G., Gruber, H.-J., & Herrmann, M. (2020) · Aging · doi:10.18632/aging.103504 · Cited by 49
“Shelterin proteins play a key role in regulating the conformational state of telomeres and thus modulate TA [27, 50].”
BackgroundComposition and conservation of the telomeric complex
Kanoh, J., & Ishikawa, F. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3245-y · Cited by 59
Organization of Chromosome Ends in Ustilago maydis. RecQ-like Helicase Motifs at Telomeric Regions
Alonso, P. S., & Guzmán, P. (1998) · Genetics · doi:10.1093/genetics/148.3.1043 · Cited by 57
O’Reilly, M., Teichmann, S. A., & Rhodes, D. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)80008-6 · Cited by 66
SA1 binds directly to DNA via its unique AT-hook to promote sister chromatid cohesion at telomeres
Bisht, K. K., Daniloski, Z., & Smith, S. H. (2013) · Journal of Cell Science · doi:10.1242/jcs.130872 · Cited by 59
Klapper, W., Krams, M., Qian, W., Janssen, D., & Parwaresch, R. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601112 · Cited by 52
Fransson, P., & Widmark, A. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<678::aid-cncr18>3.0.co;2-e · Cited by 79
Telomerase regulation and telomere dynamics in germinal centers
Norrback, K., Hultdin, M., Dahlenborg, K., Osterman, P., Carlsson, R., & Roos, G. (2001) · European Journal of Haematology · doi:10.1034/j.1600-0609.2001.00588.x · Cited by 49
Induction of Telomerase Activity by Irradiation in Human Lymphoblasts
Neuhof, D., Ruess, A., Wenz, F. K., & Weber, K. J. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0693:iotabi]2.0.co;2 · Cited by 49
“Studies in yeast and human cells indicate that cells count telomere-binding proteins to determine their telomere length (34, 35).”
BackgroundProteins that bind to double-stranded regions of telomeric DNA
Brun, C., Marcand, S., & Gilson, É. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01092-1 · Cited by 52
Kong, L.-J., Meloni, A. R., & Nevins, J. R. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.02.016 · Cited by 48
The substrates of Plk1, beyond the functions in mitosis
Liu, X. S., Song, B., & Liu, X. (2010) · Protein & Cell · doi:10.1007/s13238-010-0131-x · Cited by 49
“In addition to the roles in mitosis, Trf1 also functions as a negative regulator of telomere maintenance, since expression of a dominant-negative mutant results in elongation of telomeres, and overexpression of WT Trf1 shortens telomeres ( van Steensel and de Lange, 1997 ).”
BackgroundThe programmed aging paradigm: How we get old
Libertini, G. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914100034 · Cited by 51
Telomere Length: A Potential Biomarker for the Risk and Prognosis of Stroke
Tian, Y., Wang, S., Jiao, F., Kong, Q., Liu, C., & Wu, Y. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00624 · Cited by 55
Plk1 Phosphorylation of TRF1 Is Essential for Its Binding to Telomeres
Wu, Z.-Q., Yang, X., Weber, G. J., & Liu, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803304200 · Cited by 48
New inhibitors of poly(ADP-ribose) polymerase and their potential therapeutic targets
Cosi, C. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.7.1047 · Cited by 49
“Binding of TRF1 to telomere repeats inhibits the function of telomerase, thus contributing to telomere shortening during replication [30].”
BackgroundTelomerase activity and telomere length in thyroid neoplasia: biological and clinical implications
Matthews, P., Jones, C. J., Skinner, J. W., Haughton, M. F., Micco, C. D., & Wynford‐Thomas, D. (2001) · The Journal of Pathology · doi:10.1002/path.848 · Cited by 52
“In humans they comprise multiple repeats of the 6-base pair sequence TTAGGG, in total amounting to 3–12 kilobase pairs (kbp) [1], together with associated binding proteins such as TRF1 and TRF2 [2,3].”
BackgroundCST–Polα/Primase: the second telomere maintenance machine
Cai, S. W., & de Lange, T. (2023) · Genes & Development · doi:10.1101/gad.350479.123 · Cited by 55
“It has long been known that TRF1, TIN2, and POT1 prevent excessive telomerase-mediated elongation at individual telomere ends (van Steensel and de Lange 1997; Kim et al. 1999; Loayza and De Lange 2003), enforcing the telomere length homeostasis critical to human health.”
Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia
Savage, S. A., Calado, R. T., Xin, Z.-T., Ly, H., Young, N. S., & Chanock, S. J. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.02.008 · Cited by 47
“Two mg of genomic DNA was digested with HinfI and RsaI restriction enzymes and then separated on agarose gels.”
BackgroundInfluential
Metadata
- Authors
- van Steensel, B., & de Lange, T.
- Venue
- Nature
- Published
- 1997-02
- Volume
- 385
- Issue
- 6618
- Pages
- 740-743
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086992094
- Semantic Scholar
- 080771c5a8e8b8bc6d55561a31326094194412ea
- Cited by
- 1,219
- References
- 30
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 26 · 2023: 27 · 2022: 13 · 2021: 35 · 2020: 25 · 2019: 25 · 2018: 28 · 2017: 32 · 2016: 30 · 2015: 28 · 2014: 44 · 2013: 37 · 2012: 32
- FWCI
- 43.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- TRF1, telomere length regulation, telomerase, telomere shortening, telomere elongation, telomere binding, negative feedback loop, cancer cells, immortalized cells, TTAGGG repeats
- MeSH terms
- DNA-Binding Proteins, Feedback, Genes, Dominant, HeLa Cells, Humans, Mutation, Recombinant Proteins, Tumor Cells, Cultured, Telomere, Telomerase, Telomeric Repeat Binding Protein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.